CORC  > 山东大学
miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways
Zhang, Shuai; Li, Dong; Jiao, Guang-jun; Wang, Hong-liang; Yan, Ting-bin
刊名ONCOTARGETS AND THERAPY
2018
卷号11页码:7967-7977
关键词miR-185 PI3K/Akt/mTOR pathway Wnt/beta-catenin pathway E2F6 Ewing's sarcoma
DOI10.2147/OTT.S167771
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4572465
专题山东大学
作者单位Shandong Univ, Qilu Hosp, Dept Orthoped, 107 Rd Wenhuaxi, Jinan 250012, Shandong, Peo
推荐引用方式
GB/T 7714
Zhang, Shuai,Li, Dong,Jiao, Guang-jun,et al. miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways[J]. ONCOTARGETS AND THERAPY,2018,11:7967-7977.
APA Zhang, Shuai,Li, Dong,Jiao, Guang-jun,Wang, Hong-liang,&Yan, Ting-bin.(2018).miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways.ONCOTARGETS AND THERAPY,11,7967-7977.
MLA Zhang, Shuai,et al."miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways".ONCOTARGETS AND THERAPY 11(2018):7967-7977.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace